Catvision Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 4:20 pm

Competitors of Catvision Ltd

All Competitor Stocks of Catvision Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:35 am

Below is a detailed analysis of the quarterly data for Catvision Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 4.79 Cr.. The value appears to be declining and may need further review. It has decreased from 4.90 Cr. (Dec 2024) to 4.79 Cr., marking a decrease of 0.11 Cr..
• For Expenses, as of Mar 2025, the value is 5.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.81 Cr. (Dec 2024) to 5.20 Cr., marking an increase of 0.39 Cr..
• For Operating Profit, as of Mar 2025, the value is -0.41 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Dec 2024) to -0.41 Cr., marking a decrease of 0.50 Cr..
• For OPM %, as of Mar 2025, the value is -8.56%. The value appears to be declining and may need further review. It has decreased from 1.84% (Dec 2024) to -8.56%, marking a decrease of 10.40%.
• For Other Income, as of Mar 2025, the value is 0.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Dec 2024) to 0.32 Cr., marking an increase of 0.23 Cr..
• For Interest, as of Mar 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.01 Cr..
• For Depreciation, as of Mar 2025, the value is 0.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Dec 2024) to 0.22 Cr., marking an increase of 0.09 Cr..
• For Profit before tax, as of Mar 2025, the value is -0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Dec 2024) to -0.32 Cr., marking a decrease of 0.36 Cr..
• For Tax %, as of Mar 2025, the value is 81.25%. The value appears to be increasing, which may not be favorable. It has increased from -250.00% (Dec 2024) to 81.25%, marking an increase of 331.25%.
• For Net Profit, as of Mar 2025, the value is -0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 0.13 Cr. (Dec 2024) to -0.57 Cr., marking a decrease of 0.70 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.05. The value appears to be declining and may need further review. It has decreased from 0.24 (Dec 2024) to -1.05, marking a decrease of 1.29.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:41 am

Growth

Last Updated: September 5, 2025, 2:51 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Catvision Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.77. This value is below the healthy minimum of 5. It has decreased from 10.99 (Mar 24) to -0.77, marking a decrease of 11.76.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.77. This value is below the healthy minimum of 5. It has decreased from 10.99 (Mar 24) to -0.77, marking a decrease of 11.76.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 3. It has decreased from 12.46 (Mar 24) to 0.62, marking a decrease of 11.84.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.16. It has decreased from 42.94 (Mar 24) to 42.16, marking a decrease of 0.78.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.16. It has decreased from 42.94 (Mar 24) to 42.16, marking a decrease of 0.78.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.94. It has increased from 36.84 (Mar 24) to 36.94, marking an increase of 0.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 2. It has increased from 0.58 (Mar 24) to 0.98, marking an increase of 0.40.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 0. It has increased from -0.68 (Mar 24) to -0.19, marking an increase of 0.49.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.26. This value is below the healthy minimum of 0. It has decreased from 11.25 (Mar 24) to -0.26, marking a decrease of 11.51.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 2. It has decreased from 11.18 (Mar 24) to -0.55, marking a decrease of 11.73.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.58. This value is below the healthy minimum of 2. It has decreased from 11.00 (Mar 24) to -0.58, marking a decrease of 11.58.
• For PBDIT Margin (%), as of Mar 25, the value is 2.66. This value is below the healthy minimum of 10. It has increased from 1.59 (Mar 24) to 2.66, marking an increase of 1.07.
• For PBIT Margin (%), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 10. It has increased from -1.86 (Mar 24) to -0.52, marking an increase of 1.34.
• For PBT Margin (%), as of Mar 25, the value is -0.71. This value is below the healthy minimum of 10. It has decreased from 30.53 (Mar 24) to -0.71, marking a decrease of 31.24.
• For Net Profit Margin (%), as of Mar 25, the value is -1.50. This value is below the healthy minimum of 5. It has decreased from 30.35 (Mar 24) to -1.50, marking a decrease of 31.85.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 8. It has decreased from 29.85 (Mar 24) to -1.59, marking a decrease of 31.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is -1.39. This value is below the healthy minimum of 15. It has decreased from 25.61 (Mar 24) to -1.39, marking a decrease of 27.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is -0.43. This value is below the healthy minimum of 10. It has increased from -1.56 (Mar 24) to -0.43, marking an increase of 1.13.
• For Return On Assets (%), as of Mar 25, the value is -0.97. This value is below the healthy minimum of 5. It has decreased from 20.50 (Mar 24) to -0.97, marking a decrease of 21.47.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.65. It has decreased from 0.78 (Mar 24) to 0.65, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 3.41 (Mar 24) to 1.90, marking a decrease of 1.51.
• For Quick Ratio (X), as of Mar 25, the value is 1.31. This value is within the healthy range. It has decreased from 2.16 (Mar 24) to 1.31, marking a decrease of 0.85.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.82. This value is below the healthy minimum of 4. It has increased from 0.43 (Mar 24) to 1.82, marking an increase of 1.39.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 13.51. This value is within the healthy range. It has increased from -17.03 (Mar 24) to 13.51, marking an increase of 30.54.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -6.64. This value is below the healthy minimum of 3. It has decreased from 21.81 (Mar 24) to -6.64, marking a decrease of 28.45.
• For Enterprise Value (Cr.), as of Mar 25, the value is 9.82. It has increased from 5.17 (Mar 24) to 9.82, marking an increase of 4.65.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.48, marking an increase of 0.23.
• For EV / EBITDA (X), as of Mar 25, the value is 18.27. This value exceeds the healthy maximum of 15. It has increased from 16.14 (Mar 24) to 18.27, marking an increase of 2.13.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.66, marking an increase of 0.11.
• For Price / BV (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.58, marking an increase of 0.11.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.66, marking an increase of 0.11.
• For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.54 (Mar 24) to -0.02, marking a decrease of 0.56.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness